Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aduhelm, the Alzheimer’s drug approved this summer in a process that led some FDA advisers to quit , is the subject of new controversy. A 75-year-old woman in Canada participating...
November is Alzheimer's Awareness Month and doctors continue to explore the effects of the new drug 'Aduhelm'.
Brigham and Women's Hospital is conducting the first human trial of an Alzheimer's nasal vaccine meant to prevent or slow the disease's progression.
Test your knowledge of this week’s health news.
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many cases were asymptomatic.